InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Tango Therapeutics, Inc.. Director active across 1 companies, notably Blueprint Medicines Corp. In total, 2 disclosures have been published. The latest transaction was filed on 8 December 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
03,400 shares0
Common Stock
SEC:0001179110-21-010826·
03,400 shares0
Common Stock
SEC:0001179110-21-010826:0·
2 of 2 declarations
